Tibia fracture followed by limb immobilization in rats evokes nociceptive and vascular changes resembling complex regional pain syndrome type I (CRPS I). Previously we observed that substance P (SP) and interleukin-1b (IL-1b) signaling contribute to chronic regional nociceptive sensitization in this model. It is known that inflammasome multi-protein complexes containing caspase-1 and NALP1 are involved in the activation of the IL-1b family of pro-nociceptive cytokines expressed in skin and other tissues. Therefore, we hypothesized that SP activated inflammasomes might contribute to mechanical allodynia after fracture. Using this model we observed that: (1) inflammasome components and products NALP1, caspase-1, IL-1b and IL-18 were present in low levels in normal skin, but expression of all these was strongly up-regulated after fracture, (2) NALP1, caspase-1 and IL-1b were co-expressed in keratinocytes, and the number of NALP1, caspase-1, and IL-1b positive cells dramatically increased at 4 weeks post-fracture, (3) LY303870, an NK1 receptor antagonist, effectively blocked fracture-induced up-regulation of activated inflammasome components and cytokines, (4) IL-1b and IL-18 intraplantar injection induced mechanical allodynia in normal rats, and (5) both a selective caspase-1 inhibitor and an IL-1 receptor antagonist attenuated fracture-induced hindpaw mechanical allodynia. Collectively, these data suggest that NALP1 containing inflammasomes activated by NK1 receptors are expressed in keratinocytes and contribute to post-traumatic regional nociceptive sensitization. These findings highlight the possible importance of neuro-cutaneous signaling and innate immunity mechanisms in the development of CRPS.
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Introduction
Complex regional pain syndrome (CRPS) is a frequent consequence of distal tibia [43] and radius fractures [1]. Recently we described a distal tibia fracture model in rats that exhibits chronic unilateral hindlimb warmth, edema, facilitated protein extravasation, allodynia, unweighting, and periarticular osteoporosis, a constellation of nociceptive, vascular, and bone changes closely resembling CRPS type (CPRS I) [13] . Using this model we observed elevated levels of interleukin-1b (IL-1b) and other cytokines in the hindpaw skin of the fractured limb [39, 40, 53] . Consistent with the animal model, patients with CRPS also exhibit increased inflammatory cytokine levels in the affected limb [12, 16, 17, 33] . Importantly, the continuous administration of the IL-1 receptor antagonist (IL1ra) anakinra reduced fracture-induced nociceptive sensitization in the rat fracture model [26] . In situ hybridization and immunostaining demonstrated that epidermal keratinocytes were the main source of . The mechanisms underlying the post-traumatic up-regulation of cutaneous cytokines remain unclear, however.
Inflammasomes are multi-protein complexes responsible for the activation of caspase-1, a protease required for the processing and activation of pro-inflammatory cytokines IL-1b, 27, 29, 30, 36] . The first of these, IL-1b, is a particularly well studied human and animal algogen. To date, three different inflammasomes have been described, and they are defined by the NODlike receptor (NLR) protein they contain: the NALP1 (Nacht, leucine-rich repeat and pyrin domain containing protein) inflammasome, the NALP3 inflammasome, and the IPAF inflammasome. Abbreviations: SP, substance P; NK1R, substance P NK1 receptor; IL-1b, interleukin-1b; IL-1bR, interleukin-1b receptor; IL-18, interleukin 18; IL-18R, interleukin 18 receptor; NALP, Nacht leucine-rich repeat and pyrin domain containing protein; ASC, caspase-activating recruitment domain; NGF, nerve growth factor; TRKA, high affinity neurotropin receptor. 
